KE Holdings Inc vs Nuwellis Inc — how do they compare? KE Holdings Inc trades at $17.39 (market cap $19.21B), while Nuwellis Inc trades at $1.5 (market cap $522.76K). The key difference: KE Holdings Inc is far larger — about 36747.3× Nuwellis Inc's market cap, and KE Holdings Inc pays a 1.56% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| BEKE | NUWE | |
|---|---|---|
Market Cap | $19.21B | $522.76K |
Sector | Technology | Technology |
52-Week High | $20.36 | $220.50 |
52-Week Low | $14.26 | $1.42 |
Enterprise Value | $14.96B | -$1.29M |
Dividend Yield | 1.56% | — |
Signals from Pluang's Aura AI — not financial advice
BEKE trades at $17.04, up 0.71% with strong analyst support (91.67% buy ratings). The stock shows bullish technical signals with recent Q1 2026 earnings beating expectations at $0.20 EPS versus $0.14 forecast. Despite revenue declining from $94.58B in 2025 to $90.1B projected for 2026, net profit margin improved to 3.76% with better cost controls.
Outlook remains positive given technical momentum and fundamental improvements, though risks include China's property market volatility and competitive pressures. The company's transition to higher profitability supports potential upside, but investors should monitor housing market trends and execution on cost efficiency targets.
NUWE trades at $1.49, down 8.59% over the past day, with a bearish technical outlook. The company reported a net loss of $17.52M in 2025, with a negative net income margin of -217.22%, though it has shown revenue growth and recent strategic expansions in pediatric care. A recent 35:1 reverse stock split was executed on June 26, 2026.
The outlook remains high-risk due to persistent losses and cash burn, but growth initiatives and new product development offer potential. Key risks include execution challenges and dependence on financing. Analyst sentiment is mixed, with a 50% buy and 50% hold rating among covered analysts.
Trailing returns across standard periods
KE Holdings (Beike) is China’s leading platform for housing transactions and services. It operates the Lianjia brand and uses data-driven technology to facilitate home sales, rentals, and home renovation services.
Read more on BEKE →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →